study, which I might add is being run by the HEAD of the Infectious disease division of Johns Hopkins shows results as expected (or better). And I say as expected, because Zenilman is taking this on for a reason!!!!! Then, announcing it is on to a study on infected patients.....this stock is gonna pop big time, likely over $2...minimum. Then, add to this, the facility being inspected and ready, plus, MK trial enrollment and we havehuge upside and very little downside risk at this point. IMO, it's a better buy now, knowing what we know and what is coming. Remember, MK is for real and the lab is for real, and both are imminent. LEAPs MAY, just may be the sexier kicker that launches us into the mid single digits, but we have a real infrustucture now. VERY positive.
It is good to see people with reason here. Know where you stand. Like somebody posted here yesterday that we're already are testing at JH, based on the previous PR. Understanding the statements correctly is crucial. Let's not get ahead of ourselves. It'll help us all. Indeed this is just the beginning, and IMO very positive developments from here on out.
Cmeg, Thank you for your honest response. I'm not a medical person or obviously as seasoned as you. So by reading other posts, the results could be in anywhere from 3-14 days average, maybe? Not that it matters, I'm long, but still to start with a company at .36, and start to see things come to fruitation, well, just makes me giddy with excitement. I know you've been around much longer, so I'm really happy for all those "old timer" longs. Take care!
Jake, One thing I don't like to do is invest on the basis of a timetable. Ive learned that all it does is create disappointment. My expectations are for benchmarks to be met. Events. Results. Not time. I'm sorry, I just won't go there on a public forum. The fact that Zenilman is running this study is a tell. He is already planning the next study. He already thinks he knows the results, IMO.